Common Stock, Shares, Issued of Theriva Biologics, Inc. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Theriva Biologics, Inc. quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • Theriva Biologics, Inc. Common Stock, Shares, Issued for the quarter ending 31 Dec 2025 was 35,717,159, a 1171% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Theriva Biologics, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 35,717,159 +32,905,900 +1171% 31 Dec 2025 10-K 12 Mar 2026 2025 FY
Q3 2025 10,333,572 +7,687,300 +290% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 9,088,042 -14,025,349 -61% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 2,811,259 -15,057,023 -84% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 2,811,259 +2,096,231 +293% 31 Dec 2024 10-K 12 Mar 2026 2025 FY
Q3 2024 2,646,272 -15,116,726 -85% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 23,113,391 +5,351,381 +30% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 17,868,282 +2,023,988 +13% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 715,028 -15,129,033 -95% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 17,762,998 +1,918,704 +12% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 17,762,010 +1,917,716 +12% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 15,844,294 -142,595,874 -90% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 15,844,061 +2,639,574 +20% 31 Dec 2022 10-K 25 Mar 2024 2023 FY
Q3 2022 15,844,294 -116,200,572 -88% 30 Sep 2022 10-K 30 Mar 2023 2022 FY
Q2 2022 15,844,294 -116,200,572 -88% 30 Jun 2022 10-K 30 Mar 2023 2022 FY
Q1 2022 158,440,168 +26,395,302 +20% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 13,204,487 -16,047,766 -55% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 132,044,866 +112,199,583 +565% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 132,044,866 +113,398,714 +608% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 132,044,866 +114,303,063 +644% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 29,252,253 +12,443,495 +74% 31 Dec 2020 10-K 16 Mar 2022 2021 FY
Q3 2020 19,845,283 +3,036,525 +18% 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 18,646,152 +1,998,264 +12% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 17,741,803 +1,356,523 +8.3% 31 Mar 2020 10-Q 05 May 2020 2020 Q1
Q4 2019 16,808,758 +1,324,347 +8.6% 31 Dec 2019 10-K 04 Mar 2021 2020 FY
Q3 2019 16,808,758 +11,462,084 +214% 30 Sep 2019 10-Q 04 Nov 2019 2019 Q3
Q2 2019 16,647,888 -113,732,629 -87% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 16,385,280 -112,263,085 -87% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 15,484,411 +11,811,069 +322% 31 Dec 2018 10-K 20 Feb 2020 2019 FY
Q3 2018 5,346,674 -123,301,691 -96% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 130,380,517 +2,552,939 +2% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 128,648,365 +10,630,672 +9% 31 Mar 2018 10-Q 08 May 2018 2018 Q1
Q4 2017 3,673,342 -113,580,854 -97% 31 Dec 2017 10-K 27 Feb 2019 2018 FY
Q3 2017 128,648,365 +36,914,532 +40% 30 Sep 2017 10-Q 01 Nov 2017 2017 Q3
Q2 2017 127,827,578 +36,476,510 +40% 30 Jun 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 118,017,693 +27,109,459 +30% 31 Mar 2017 10-Q 04 May 2017 2017 Q1
Q4 2016 117,254,196 +26,345,962 +29% 31 Dec 2016 10-K 22 Feb 2018 2017 FY
Q3 2016 91,733,833 +842,265 +0.93% 30 Sep 2016 10-Q 01 Nov 2016 2016 Q3
Q2 2016 91,351,068 +18,090,281 +25% 30 Jun 2016 10-Q 03 Aug 2016 2016 Q2
Q1 2016 90,908,234 +18,182,247 +25% 31 Mar 2016 10-Q 05 May 2016 2016 Q1
Q4 2015 90,908,234 +18,313,608 +25% 31 Dec 2015 10-K 02 Mar 2017 2016 FY
Q3 2015 90,891,568 +32,356,558 +55% 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 73,260,787 +14,725,777 +25% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 72,725,987 +14,201,935 +24% 31 Mar 2015 10-Q 11 May 2015 2015 Q1
Q4 2014 72,594,626 +14,298,818 +25% 31 Dec 2014 10-K 10 Mar 2016 2015 FY
Q3 2014 58,535,010 +13,799,114 +31% 30 Sep 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 58,535,010 +13,799,114 +31% 30 Jun 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 58,524,052 +13,788,156 +31% 31 Mar 2014 10-Q 15 May 2014 2014 Q1
Q4 2013 58,295,808 +13,851,578 +31% 31 Dec 2013 10-K 16 Mar 2015 2014 FY
Q3 2013 44,735,896 +11,258,876 +34% 30 Sep 2013 10-Q 14 Nov 2013 2013 Q3
Q2 2013 44,735,896 +11,353,267 +34% 30 Jun 2013 10-Q 14 Aug 2013 2013 Q2
Q1 2013 44,735,896 +11,878,287 +36% 31 Mar 2013 10-Q 15 May 2013 2013 Q1
Q4 2012 44,444,230 +13,070,228 +42% 31 Dec 2012 10-K 31 Mar 2014 2013 FY
Q3 2012 33,477,020 +5,349,376 +19% 30 Sep 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 33,382,629 +5,303,503 +19% 30 Jun 2012 10-Q/A 11 Sep 2012 2012 Q2
Q1 2012 32,857,609 31 Mar 2012 10-Q 15 May 2012 2012 Q1
Q4 2011 31,374,002 +7,953,813 +34% 31 Dec 2011 10-K 16 Apr 2013 2012 FY
Q3 2011 28,127,644 30 Sep 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 28,079,126 30 Jun 2011 10-Q 15 Aug 2011 2011 Q2
Q4 2010 23,420,189 31 Dec 2010 10-K/A 11 May 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.